Neil Harris Cohen is a director of Chemomab Therapeutics Ltd.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Chemomab Therapeutics Ltd.
23 Mar 23
4
Chemomab Therapeutics Ltd.
18 Nov 22
4
Chemomab Therapeutics Ltd.
19 May 22
4
Chemomab Therapeutics Ltd.
15 Mar 22
4
Chemomab Therapeutics Ltd.
9 Mar 22
4
Chemomab Therapeutics Ltd.
8 Dec 21
4
Chemomab Therapeutics Ltd.
21 Apr 21
4
Chemomab Therapeutics Ltd.
26 Mar 21
4
Anchiano Therapeutics Ltd.
11 Mar 21
3
Anchiano Therapeutics Ltd.
11 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Mar 23 | CMMB Chemomab Therapeutics | Option to Purchase American Depositary Shares American Depositary Shares | Grant | Acquire A | No | No | 1.62 | 6,875 | 11.14 k | 6,875 |
7 Mar 22 | CMMB Chemomab Therapeutics | Option to Purchase American Depositary Shares American Depositary Shares | Grant | Acquire A | No | No | 3.53 | 6,820 | 24.07 k | 6,820 |
19 Apr 21 | CMMB Chemomab Therapeutics | Option to Purchase American Depositary Shares American Depositary Shares | Grant | Acquire A | No | No | 27.26 | 11,884 | 323.96 k | 11,884 |
16 Mar 21 | CMMB Chemomab Therapeutics | Option to Purchase American Depositary Shares American Depositary Shares | Grant | Acquire A | No | No | 13.17 | 688 | 9.06 k | 688 |